Approval · Notice of Compliance 9937 · 2008
STELARA: Notice of Compliance 9937
Issued December 12, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9937
- Date
- December 12, 2008
- Company
- Janssen-Ortho Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Selective immunomodulating agent
Products in this notice
Medicinal ingredients
- USTEKINUMAB 45 MG per 0.5ML
- USTEKINUMAB 90 MG per ML